NCT05813886

Brief Summary

effect of post covid-19 on dynamic balance in patients after recovery from covid-19 disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 20, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 21, 2023

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

April 11, 2023

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 14, 2023

Completed
Last Updated

April 19, 2023

Status Verified

April 1, 2023

Enrollment Period

10 months

First QC Date

April 11, 2023

Last Update Submit

April 15, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • overall (OA), the anteroposterior (AP) and the Medio lateral (ML) stability scores

    A high score in the OA index indicates poor balance. The OA stability score is believed to be the best indicator of the overall ability of the patient to balance the platform

    2 to24 WEEKS after their recovery from the disease

Interventions

The balance tests of the patients were performed 2 to24 WEEKS after their recovery from the disease, which was confirmed by the evaluations of the Covid-19 staff and negative polymerase chain reaction test.

Eligibility Criteria

Age30 Years - 40 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsMALE AND FEMALE
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

25 patients (males and females) who recovered from Covid-19 disease will be selected from 6 october unversity Hospital outpatient Clinic their age from 30 -40 years old and 25 healthyage and gender matched (males and females

You may qualify if:

  • post COVID-19 patients suffering from inbalance.
  • Age will be ranged from 30 to 40 years old.
  • Body mass index (BMI) will be ranged from 25 to 35 Kg/m2.
  • Diagnosed as COVID-19 patients with a positive reverse transcription polymerase chain reaction (RT-PCR) result of SARS-CoV-2, or typical computerized tomography (CT) evidence of viral pneumonia.
  • All enrolled patients with moderate covid-19 infection.

You may not qualify if:

  • Severe disease or hospitalization at intensive care units will excluded from the study.
  • Patients with previous hearing problems or balance disorders.
  • Patients who had ear surgery, cardiovascular and circulatory problems,.
  • Patients with orthopedic problems in the lower extremities due to other problems
  • Patients with Any history of neurological or psychiatric disease, severe visual or auditory impairments.
  • Diabetic patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

October 6 u

El-Sheikh Zayed City, Giza Governorate, 1133, Egypt

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

April 11, 2023

First Posted

April 14, 2023

Study Start

February 20, 2022

Primary Completion

December 30, 2022

Study Completion

March 21, 2023

Last Updated

April 19, 2023

Record last verified: 2023-04

Locations